Home › Funds › Parkman Healthcare Partners LLC › ANIP
Parkman Healthcare Partners LLC position in ANIP
ANI PHARMACEUTICALS INC · Health Care
Parkman Healthcare Partners LLC reported holding 185,855 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$13.5M, representing 1.22% of its reported portfolio and ranking #31 among its reported holdings. Parkman Healthcare Partners LLC has disclosed ANIP holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's ANIP position evolved
Parkman Healthcare Partners LLC first disclosed a stake in ANIP in Q3 2023 at 111,802 shares (US$6.5M). The position peaked in Q1 2026 at 280,575 shares, worth US$21.6M. Across 7 filings, Parkman Healthcare Partners LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 185,855 shares valued at US$13.5M — a reduction of -17,052 shares quarter over quarter.. Notable position changes include a 94% increase in Q1 2026 (shares rose 8% over the following quarter), a 28% trim in Q2 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 111.80K | $6.49M | New |
| Q1 2025 | 105.00K | $7.03M | New |
| Q2 2025 | 128.48K | $8.38M | Add |
| Q4 2025 | 145.00K | $11.45M | New |
| Q1 2026 | 280.57K | $21.58M | Add |
| Q2 2026 | 202.91K | $16.80M | Reduce |
| Q3 2026 | 185.85K | $13.50M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANIP and 13F data
ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Deep Track Capital, LP (US$36.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANIP
- Soleus Capital Management, L.P. 867.76K sh · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K sh · $58.57M · Q2 2026
- Deep Track Capital, LP 500.00K sh · $36.33M · Q3 2026
- Empyrean Capital Partners, LP 23.00M sh · $29.75M · Q2 2026
- HBK INVESTMENTS L P 20.15M sh · $23.61M · Q3 2026
- Ikarian Capital, LLC 272.08K sh · $22.52M · Q2 2026
- Ranger Investment Management, L.P. 268.63K sh · $19.52M · Q3 2026
- Boussard & Gavaudan Investment Management LLP 13.35K sh · $16.46M · Q1 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held ANIP?
Parkman Healthcare Partners LLC has disclosed ANIP holdings in 7 of the last 13 reported quarters, going back to Q3 2023.
What is Parkman Healthcare Partners LLC's current position in ANIP?
As of Q3 2026, Parkman Healthcare Partners LLC holds 185.85K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $13.50M, representing 1.22% of its reported portfolio and ranking #31.
Has Parkman Healthcare Partners LLC been buying or selling ANIP?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in ANIP. The position peaked in Q1 2026 at 280.57K shares.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Deep Track Capital, LP, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.